SGLT2-Inhibition in Patients With Alport Syndrome.

Boeckhaus J, Gale DP, Simon J, Ding J, Zhang Y, Bergmann C, Turner AN, Hall M, Sayer JA, Srivastava S, Kang HG, Cerkauskaite-Kerpauskiene A, Gillion V, Claes KJ, Krueger B, de Fallois J, Walden U, Choi M, Schueler M, Mueller RU, Todorova P, Hohenstein B, Zeisberg M, Friede T, Knebelmann B, Halbritter J, Gross O

Open source

DOI: 10.1016/j.ekir.2024.09.014
Published: 2024 Dec
Container: Kidney international reports
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ekir.2024.09.014,
  title = {SGLT2-Inhibition in Patients With Alport Syndrome.},
  author = {Boeckhaus J and Gale DP and Simon J and Ding J and Zhang Y and Bergmann C and Turner AN and Hall M and Sayer JA and Srivastava S and Kang HG and Cerkauskaite-Kerpauskiene A and Gillion V and Claes KJ and Krueger B and de Fallois J and Walden U and Choi M and Schueler M and Mueller RU and Todorova P and Hohenstein B and Zeisberg M and Friede T and Knebelmann B and Halbritter J and Gross O},
  year = {2024},
  journal = {Kidney international reports},
  doi = {10.1016/j.ekir.2024.09.014},
  url = {https://doi.org/10.1016/j.ekir.2024.09.014}
}

RIS

TY  - JOUR
TI  - SGLT2-Inhibition in Patients With Alport Syndrome.
AU  - Boeckhaus J
AU  - Gale DP
AU  - Simon J
AU  - Ding J
AU  - Zhang Y
AU  - Bergmann C
AU  - Turner AN
AU  - Hall M
AU  - Sayer JA
AU  - Srivastava S
AU  - Kang HG
AU  - Cerkauskaite-Kerpauskiene A
AU  - Gillion V
AU  - Claes KJ
AU  - Krueger B
AU  - de Fallois J
AU  - Walden U
AU  - Choi M
AU  - Schueler M
AU  - Mueller RU
AU  - Todorova P
AU  - Hohenstein B
AU  - Zeisberg M
AU  - Friede T
AU  - Knebelmann B
AU  - Halbritter J
AU  - Gross O
PY  - 2024
JO  - Kidney international reports
DO  - 10.1016/j.ekir.2024.09.014
UR  - https://doi.org/10.1016/j.ekir.2024.09.014
ER  -

APA

J, B., DP, G., J, S., J, D., Y, Z., C, B., AN, T., M, H., JA, S., S, S., HG, K., A, C., V, G., KJ, C., B, K., J, D. F., U, W., M, C., M, S., RU, M., P, T., B, H., M, Z., T, F., B, K., J, H., & O, G. (2024). SGLT2-Inhibition in Patients With Alport Syndrome.. Kidney international reports. https://doi.org/10.1016/j.ekir.2024.09.014

Source records

pubmed · retrieved 2026-09-26T14:25:54.202Z
europe-pmc · retrieved 2026-09-26T14:25:54.195Z
doaj · retrieved 2026-09-26T14:25:54.174Z